LPT
TECH icon

Legacy Private Trust’s Bio-Techne TECH Stock Holding History

Legacy Private Trust’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,000
Closed -$329K – 231
2019
Q4 		$329K Hold
6,000
– – 0.03% 196
2019
Q3 		$294K Hold
6,000
– – 0.03% 205
2019
Q2 		$313K Buy
+6,000
New +$302K 0.04% 203

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Legacy Private Trust's TECH Position: Q1 2020 in Review

Legacy Private Trust sold out of Bio-Techne (TECH) in Q1 2020, closing a stake of 6,000 shares — an estimated $329K sold.

Legacy Private Trust first reported a position in TECH in Q2 2019 and held it in 3 quarters. The position peaked at $329K in Q4 2019. 368 funds tracked by Wall St. Rank hold TECH as of Q1 2020.

  • Legacy Private Trust reported no remaining Bio-Techne position as of Q1 2020 after selling out during the quarter.
  • Legacy Private Trust sold 6,000 Bio-Techne shares in Q1 2020, an estimated $329K.
  • Legacy Private Trust first reported a position in Bio-Techne in Q2 2019 and held it in 3 quarters.
  • Legacy Private Trust's Bio-Techne position peaked at $329K in Q4 2019.
  • 368 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2020.

Based on Legacy Private Trust's 13F filing for Q1 2020, filed 23 Apr 2020.